Dillaha and Rothman were the first to report the remarkable therapeutic effect of systemic cortisone on alopecia areata.1 During the intervening seven-year period new members of the cortisone family have been shown to have a similar effect.2 We wish to report here a striking result obtained with triamcinolone (Aristocort),* one of the most recent and potent corticosteroids yet synthesized.3
Report of a Case
This 18-year-old, healthy, white youth was first seen by us on Sept. 16, 1957, for the treatment of alopecia, which had been present since the age of 9 years. His hair loss had begun as two patches on the scalp, after the psychic trauma of being thrown into a swimming pool by elders who knew he could not swim. The hair loss had gradually extended to involve the entire scalp, eyebrows, and eyelashes. Terminal axillary hair had not appeared at puberty, although
SHELLEY WB, HARUN JS, LEHMAN JM. Long-Term Triamcinolone Therapy of Alopecia Universalis: Case Report. AMA Arch Derm. 1959;80(4):433–435. doi:https://doi.org/10.1001/archderm.1959.01560220043008
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: